focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKanabo Grp Plc Regulatory News (KNB)

Share Price Information for Kanabo Grp Plc (KNB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.70
Bid: 1.60
Ask: 1.80
Change: -0.10 (-5.88%)
Spread: 0.20 (12.50%)
Open: 1.70
High: 1.60
Low: 1.60
Prev. Close: 1.70
KNB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

30 Jun 2022 17:02

RNS Number : 9033Q
Kanabo Group PLC
30 June 2022
 

 

Kanabo Group Plc.

Result of Annual General Meeting

 

Kanabo Group Plc is pleased to announce that, at the Annual General Meeting ("AGM") held earlier today, all resolutions were duly passed. The numbers of votes for each resolution are presented below:

 

 

 

Chairman of the meeting

FOR

Chairman of the meeting

AGAINST

 

 

 

 

Total Votes Cast

ABSTAIN

Resolution

 

No. of shares

%

No. of shares

%

1

Receive Financial Statements

115,542,133

99.75451

284,339

0.245487

115,826,472

142,706

2

Approve the Directors' Remuneration Report

115,458,280

99.69236

356,288

0.307637

115,814,568

154,610

3

Approve the re-appointment of the auditors and authorize the directors to determine the Auditors' Remuneration

115,553,226

99.75257

286,620

0.247428

115,839,846

129,332

4

Re-elect Andrew Morrison

113,469,744

97.99032

2,327,150

2.009683

115,796,894

172,284

5

Re-elect Avihu Israel Tamir

115,502,424

99.74567

294,510

0.254333

115,796,934

172,244

6

Re-elect David Tsur

115,508,799

99.75078

288,595

0.249224

115,797,394

171,784

7

Elect Daniel Poulter

115,509,839

99.75164

287,595

0.24836

115,797,434

171,744

8

Elect Gil Efron

115,509,839

99.75164

287,595

0.24836

115,797,434

171,744

9

Authorise the directors to allot securities

115,468,984

99.72081

323,278

0.279188

115,792,262

176,916

10*

Authorise the directors to allot Equity Securities

115,469,484

99.72081

323,278

0.279187

115,792,762

176,416

* Special Resolution

 

NOTES:

Votes "For" and "Against" are expressed as a percentage of votes received.

 

 

 

 

For further information, please visit http://www.kanabogroup.com/ or https://www.voxmarkets.co.uk/listings/LON/KNB or contact the following:

 

Kanabo Group Plc

Via Vox Markets

Avihu Tamir, CEO

 

Peterhouse Capital Ltd (Financial Adviser)

Tel: +44 (0)20 7469 0930

Eran Zucker / Lauren Riley

 

Peterhouse Capital Ltd (Corporate Broker)

 

Lucy Williams / Charles Goodfellow

Duncan Vasey / Martin Lampshire

 

 

Vox Markets (Investor Relations)

KanaboGroup@voxmarkets.co.uk

Kat Perez

kperez@voxmarkets.co.uk

 

 

About Kanabo Group Plc

Kanabo Group Plc is creating a new standard in the medical cannabis industry to improve the well-being of millions of people around the world by providing a better alternative to the smoking of medicinal cannabis flowers. Kanabo, which was the first medicinal cannabis company to IPO on London Stock Exchange, has a focus on the distribution of cannabis-derived products for medical patients and non-THC products for CBD consumers.

 

The Company has conducted extensive Research & Development to produce high-quality cannabis extract formulas, innovative medical-grade vaporizers, and various non-smoking consumption solutions. Kanabo sells a range of medical cannabis products and wellness CBD products in the Primary Markets, including its VapePod, which delivers a metered dose with every inhalation.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGEASKEDSKAEFA
Date   Source Headline
2nd Dec 20222:59 pmRNSResignation of Auditor
15th Nov 20227:30 amRNSUpdate re: Investment into Hellenic Dynamics
24th Oct 20227:00 amRNSKanabo appointed to BSI Steering Group Committee
30th Sep 20227:01 amRNSInvestor Webinar hosted by Vox Markets
30th Sep 20227:00 amRNSHalf-year Report
30th Aug 20222:37 pmRNSGrant of Options
19th Aug 20225:30 pmRNSAppointment of Auditor
17th Aug 20222:05 pmRNSSecond Price Monitoring Extn
17th Aug 20222:00 pmRNSPrice Monitoring Extension
3rd Aug 20229:05 amRNSSecond Price Monitoring Extn
3rd Aug 20229:00 amRNSPrice Monitoring Extension
30th Jun 20225:02 pmRNSResult of AGM
30th Jun 20223:29 pmRNSAGM Statement
16th Jun 20227:00 amRNSNew Subsidiary
9th Jun 20227:00 amRNSContract Extension
8th Jun 20221:00 pmRNSNotice of AGM
6th Jun 20227:00 amRNSFinal Results
20th May 20227:00 amRNSUpdate on the Acquisition of Materia
3rd May 20227:00 amRNSTotal Voting Rights
19th Apr 20223:00 pmRNSExercise of Options and Total Voting Rights
22nd Mar 20227:00 amRNSBoard Changes
11th Mar 202211:23 amRNSInvestor Updates
9th Mar 20227:00 amRNSMoU with Forbe Ltd
1st Mar 20222:05 pmRNSSecond Price Monitoring Extn
1st Mar 20222:00 pmRNSPrice Monitoring Extension
28th Feb 20222:00 pmRNSTotal Voting Rights
25th Feb 20227:00 amRNSDirector/PDMR Dealing
23rd Feb 20227:00 amRNSBlock listing Interim Review
22nd Feb 20229:05 amRNSSecond Price Monitoring Extn
22nd Feb 20229:00 amRNSPrice Monitoring Extension
22nd Feb 20227:00 amRNSCompany Webinar
21st Feb 20225:30 pmRNSExercise of Put Option
21st Feb 20225:15 pmRNSOversubscribed Placing to Raise £2.25m
21st Feb 20224:54 pmRNSAcquisition of GP Service Ltd
31st Jan 202211:00 amRNSTotal Voting Rights
18th Jan 20227:00 amRNSMateria Announces Trading Update for 4Q22
6th Jan 20224:41 pmRNSSecond Price Monitoring Extn
6th Jan 20224:36 pmRNSPrice Monitoring Extension
31st Dec 202111:41 amRNSTotal Voting Rights
31st Dec 202110:00 amRNSGrant of Options
30th Dec 20211:00 pmRNSAchievement of Milestones
16th Dec 20217:05 amRNSMateria Malta First Sales in Europe
15th Dec 20217:00 amRNSPatent Advancement
7th Dec 20217:00 amRNSSubmission for Bioavailability and Efficacy Trial
6th Dec 20213:45 pmRNSExercise of Options
6th Dec 20217:00 amRNSUK Moves to License e-cigarettes and vaporizers
30th Nov 20214:02 pmRNSTotal Voting Rights
29th Nov 202111:05 amRNSSecond Price Monitoring Extn
29th Nov 202111:00 amRNSPrice Monitoring Extension
26th Nov 202111:57 amRNSKanabo to present at Mello: 29 November 2021

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.